As of November 14, 2026, agilon health, inc. has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from January 7, 2026 to July 22, 2026 (Form 8-K, July 22, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like agilon health, inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-07-22
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-04-27
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-01-07
agilon health, inc. reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-01-07 to 2026-07-22. Every row below is cited to the filing it comes from, and this page adds each new change as agilon health, inc. files it.
Also on the record for agilon health, inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 12, 2026 | Stake report, Schedule 13G/A, by AQR Capital Management, LLC | 4.15% of the class | 5%+ stakes | Source |
| August 11, 2026 | Stake report, Schedule 13G/A, by THE GOLDMAN SACHS GROUP, INC. | 3.9% of the class | 5%+ stakes | Source |
| May 14, 2026 | Stake report, Schedule 13G, by AQR Capital Management, LLC | 5.87% of the class | 5%+ stakes | Source |
| May 13, 2026 | Stake report, Schedule 13G, by THE GOLDMAN SACHS GROUP, INC. | 6.1% of the class | 5%+ stakes | Source |
| January 30, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | 4.41% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G/A, by North Peak Capital Management, LLC | 9.5% of the class | 5%+ stakes | Source |
| November 5, 2025 | Stake report, Schedule 13G/A, by FMR LLC | 3.7% of the class | 5%+ stakes | Source |
| October 30, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 5.86% of the class | 5%+ stakes | Source |
| September 5, 2025 | Stake report, Schedule 13G/A, by Capital World Investors | 2.6% of the class | 5%+ stakes | Source |
| August 29, 2025 | Stake report, Schedule 13G, by North Peak Capital Management, LLC | 5.2% of the class | 5%+ stakes | Source |
| August 13, 2025 | Stake report, Schedule 13G/A, by Capital International Investors | 2.4% of the class | 5%+ stakes | Source |
| August 13, 2025 | Stake report, Schedule 13G/A, by Capital World Investors | 11% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs agilon health, inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on agilon health, inc. and the records around it.
agilon health, inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Who owns it
Companies that share a holder
- North Peak Capital Management, LLC also filed stake reports on 2 other companies: GMR Solutions Inc. (Aug 2026), HAEMONETICS CORP (May 2026)
- Capital International Investors also filed stake reports on 102 other companies: Alliance Laundry Holdings, Inc. (Nov 2026), Arxis, Inc. (Nov 2026), Astronics Corp. (Nov 2026)
- Capital World Investors also filed stake reports on 139 other companies: Align Technology, Inc. (Nov 2026), Ares Management Corp. (Nov 2026), Beazer Homes USA, Inc. (Nov 2026)
Watch agilon health, inc.
Get an email when agilon health, inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on agilon health, inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on agilon health, inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on agilon health, inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 13 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-07-22 | Reported | not named in the filing | 8-K, 2026-07-22 | ||
| 2026-04-27 | Reported | not named in the filing | 8-K, 2026-04-27 | ||
| 2026-01-07 | Reported | not named in the filing | 8-K, 2026-01-07 |
New leaders reset buying decisions — get the Full Report on agilon health, inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at agilon health, inc., with the record behind each one.
Find candidates like senior executive at agilon health, inc.Every change, in the filing's words
Reported
(the "Company") provided notice to Girish Venkatachaliah, the Company's Chief Technology Officer, that Mr. Venkatachaliah's employment with the Company will terminate effective August 1, 2026 (the "Separation Date").
- In connection with Mr. Venkatachaliah's separation from employment, the Company provided Mr. Venkatachaliah with a Severance Agreement and General Release (the "Severance Agreement") which will become effective eight days following Mr. Venkatachaliah's execution of the Severance Agreement.
- Concurrently, the Company and Mr. Venkatachaliah intend to enter into a Consulting Agreement (the "Consulting Agreement") effective as of August 1, 2026 and pursuant to which Mr. Venkatachaliah will provide the Company with transition consulting services through December 31, 2026 for no consideration other than the continued equity award vesting referenced below.
Reported
(the "Company") entered into an Employment Agreement (the "Employment Agreement") with Tim O'Rourke, pursuant to which Mr. O'Rourke will serve as the Company's Chief Executive Officer and President, reporting to the Board of Directors (the "Board").
- Mr. O'Rourke is expected to commence employment with the Company on May 7, 2026 (the "Commencement Date").
- Effective as of the Commencement Date, the Board has also appointed Mr. O'Rourke to the Board as a Class III director.
- From May 2021 to June 2025, Mr. O'Rourke, age 54, served as President of Help at Home, LLC, a home care agency providing alternatives to living in a nursing home or long-term care facility.
- Prior to his time at Help at Home, LLC, Mr. O'Rourke served as Managing Director of Marketplace for Centene Corporation from 2019 to 2020 and Chief Executive Officer of Ascension Complete LLC, a joint venture between Centene Corporation and Ascension Health, from November 2020 to May 2021.
- From 1996 to 2019, Mr. O'Rourke held several positions at Humana, Inc., including Senior Vice President of the Central Division and President of Provider Development.
- Mr. O'Rourke received a B.S. in Public Health, Health Administration from Northern Illinois University.
- As Chief Executive Officer and President, Mr. O'Rourke will be paid a base salary of $850,000 and will be eligible for an annual bonus opportunity equal to 100% of his base salary at target levels of performance.
Reported
Mr. Schwaneke will also be entitled to the vesting described in clause (ii) above if he voluntarily terminates employment with the Company more than 18 months after January 1, 2026.
- Compensatory Arrangements of Certain Officers On December 31, 2025, agilon health, inc.
- (the "Company") entered into an Amended and Restated Employment Agreement with Jeffrey Schwaneke, the Company's Chief Financial Officer and Executive Vice President (the "Amended Employment Agreement"), effective as of January 1, 2026.
- The Employment Agreement amends and restates Mr. Schwaneke's prior Employment Agreement with the Company, dated June 3, 2024 and as previously disclosed by the Company (the "Prior Employment Agreement").
- The Amended Employment Agreement is substantially the same as the Prior Employment Agreement, except as noted below.
- The Amended Employment Agreement provides for payment of accrued obligations upon termination of Mr. Schwaneke's employment, and also provides for additional severance and/or continued vesting of certain equity awards in specified circumstances.
- The Company expects to file the Amended Employment Agreement as an exhibit to a future periodic report..
Tools for this story
Each opens in a new tab, filled in for agilon health, inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
